Madhya Pradesh

Applications are invited for M.Pharm/M.Tech/Ph.D as Research Associate in Indian Institute of Science Education and Research - Government of India

Indian Institute of Science Education and Research Bhopal was created in 2008 by the Ministry of Human Resource Development, Government of India. Its mission is to provide quality science education to UG and PG students.

Wanted Production Chemist / Officer / Executive @ Symbiotec Pharmalab

Symbiotec Pharmalab Ltd., a cortico-steroids API manufacturing company based at Indore in Central India is in the business of development, production and marketing of research-based cortico steroids. Symbiotec is manufacturing cortico steroids since the year 1995 and is a WHO –GMP and ISO 9000 : 2000 certified company with a vision to cater to steroids requirement of our pharmaceuticals world.

Walk in interview for faculty positions in Sagar Group of Institutions

Sagar Institute of Technology and Management was founded by the Sagar Educational Society in the year 2002 with an objective and foresight to educate the masses in various fields of technical and professional education so as to establish the identity of the student by setting footsteps as milestone in order to define their success as future engineers and management ex

Work as Senior Research Fellow in REGIONAL MEDICAL RESEARCH CENTRE FOR TRIBALS

Following post is to be filled purely on temporary and contract basis for a period of one year under the project entitled “Evaluation of biomarkers to assess malaria severity due to P. falciparum in Central India (Chhatisgarh and Madhya Pradesh) in this Centre :-

1. Name and number of Post: Senior Research Fellow - One post

FORMULATION AND EVALUTION OF MUCOADHESIVE THERMOSENSITIVE PLURONIC LECITHIN ORGANOGEL OF CLOTRIMAZOLE FOR VAGINAL CANDIDASIS

About Authors:
Amit Jain*, Sandesh Jain, A.G. Hariharan, C.K. Sudhakar, Sanjay Jain
Department of Pharmaceutics,
Smriti College of pharmaceutical education, Indore-452001,
Madhya Pradesh, India

*amitjainpharma16@gmail.com

ABSTRACT
The present investigation deals with development of mucoadhesive thermosensitive pluronic lecithin organogel of clotrimazole for vaginal candidasis. To develop more effective treatment for vaginal candidasis, clotrimazole (CT) was formulated as pluronic lecithin organogels (PLOs). Several PLOs formulations composed of clotrimazole (1%) using the thermosensitive polymer Pluronic® F127, Soya lecithin with the mucoadhesive polymer Carbopol 934. Spreadibility, rheological behavior, drug content (%), mucoadhesive force, gelling capacity and in-vitro release profiles of the different formulations were determined. In vitro, sustained release of CT from PLOs was observed. In vivo antifungal activity of CT, tested against Candida albicans vaginitis in agar plate, was significantly prolonged after vaginal delivery using PLOs. These results indicate that CT-containing vaginal PLOs safe, convenient, and effective treatment of vaginal candidasis with reduced dosing interval.

Walk in Interview : Career opportunity in CIPLA for QC - 50 vacancies

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

GOOD DOCUMENTATION PRACTICE IN PHARMACEUTICALS

About Author:
Arif Khan,
Malhotra college of pharmacy
Bhopal, MP
RGPV Bhopal, India

 

Abstract
Document is any written statement or proof of any activity in pharmaceuticals. Documentations are to define the manufacturers system of information & control, to minimize the risk of misinterpretation & errors inherent in oral or casually written communication, to provide unambiguous procedures to be followed to provide confirmation of performance, to allow calculations to be checked & to allow tracing of batch history. Documents are a mirror to show actual image of any pharmaceutical company. Documents and products are produced in pharmaceuticals but regulatory bodies are interested to see documents first. Different documents can describe the different activity in pharma and its actual image. Various documents are producing by pharma company would be discussed below. Due to the importance given to documentation in pharma “good documentation practices” is required. Good documentation is a systematic procedure of preparation, checking, verifying, issuing, storing and reviewing of any documents. Batch record is an important document kept along with reserve sample until one year of expiry of the product, and final products are release only after proper review of BMR, even after testing of Product from QC, product would not be released without review and completing of BMR and other documents .every activity should be available written form as SOPs is a requirements of GMP. Control of document is also an important part of GDP to reduce error and misuses of any documents. Master copy for all activity should be prepared such as SOPs started from Draft copy and finalizes after checking and reviewing and Approved by QA documentation. Final copy should be printed as Master copy and stamped as “master copy” by red ink. A photocopy of master copy should be issued to concern department with stamped “control copy”. A record should be maintained for issuing any documents with sign & date. Every document should have effective date, review date and revision no.

Burning issue - Present status of Pharmaceutical Industries

“Recent acquisition of Indian generic drug companies by MNCs has increased fears that the price of low-cost generic drugs will rise in India. The buy-outs will reduce domestic availability of many essential medicines; point out an internal assessment of the health ministry, Government of India. It is ironic that despite India supplying quality generic drugs around the world, the country has concerns about sufficient domestic drug supply and vaccines security. With the increasing acquisition of Indian companies by overseas drug corporations, there is a pressing need to rethink India’s drug strategy”. This statement was released by government of India before few months. Now what global honchos think about India?

Pages